-
公开(公告)号：US20180092950A1
公开(公告)日：2018-04-05
申请号：US15843053
申请日：2017-12-15
CPC分类号： A61K35/742 , A61K35/747 , A61K2035/11 , C12R1/10 , C12R1/125 , C12R1/225 , C12R1/24 , C12R1/46
摘要： The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are Bacillus strains. In another embodiment, the strains are lactic acid bacteria.
-
公开(公告)号：US09822334B2
公开(公告)日：2017-11-21
申请号：US14200231
申请日：2014-03-07
CPC分类号： A23K30/18 , A23Y2220/13 , A23Y2220/67 , C12N1/20 , C12R1/225 , C12R1/24
摘要： A method for treating silage to enhance the aerobic stability by increasing the fermentation and stabilization of silage by inhibiting growth of microorganisms selected from yeasts, molds and spore-forming bacteria and permitting earlier aerobic 5 exposure is disclosed. The method comprises treating silage or feed with a composition comprising Lactobacillus buchneri strain LN7125, or Lactobacillus brevis strain LB5328, or Lactobacillus brevis strain LB7123, and mixtures or a mutant thereof which retains the silage preservative activity of LN7125, LB5328, or LB7123, or the antimicrobial components produced thereby. The strains of Lactobacillus 10 buchneri and Lactobacillus brevis disclosed in the invention have been purified and isolated and have been found to improve aerobic stability of silage allowing earlier aerobic exposure post ensiling than is presently practiced.
-
公开(公告)号：US20170202889A1
公开(公告)日：2017-07-20
申请号：US15247001
申请日：2016-08-25
申请人： OrganoBalance GmbH
发明人： Christine Lang , Andreas Heilmann , Markus Veen , Eckhard Budde , Mewes Boettner , Andreas Reindl , Rolf Knöll
CPC分类号： A61K35/747 , A01N63/00 , A61K8/99 , A61K9/0014 , A61K35/74 , A61K2035/11 , A61Q17/005 , A61Q19/00 , C12R1/225 , C12R1/24
摘要： Described are microorganisms which are, in a first aspect, able to stimulate the growth of microorganisms of the resident skin microbial flora and which do not stimulate the growth of microorganisms of the transient pathogenic micro flora. In a second aspect microorganisms are described which are able to inhibit the growth of microorganisms of the transient pathogenic skin micro flora and which do not inhibit the growth of microorganisms of the resident skin micro flora. Also described are compositions comprising such microorganisms as well as the use of such microorganisms in cosmetic, prophylactic or therapeutic applications.
-
4.发明申请BACTERIAL STRAIN HAVING ANTI-ALLERGIC ACTIVITY, AND BEVERAGE, FOOD AND ANTI-ALLERGIC AGENT COMPRISING CELL OF THE BACTERIAL STRAIN 审中-公开具有抗过敏活性的细菌菌株，以及包含细菌菌株的饮料，食品和抗过敏剂公开(公告)号：US20150208709A1
公开(公告)日：2015-07-30
申请号：US14682383
申请日：2015-04-09
IPC分类号： A23L1/30 , A61K35/747
CPC分类号： A23L33/135 , A23L2/40 , A23L2/52 , A23V2002/00 , A23Y2220/13 , A61K35/747 , A61K2035/115 , C12C12/008 , C12N1/20 , C12P7/52 , C12P13/005 , C12R1/24 , A23V2250/038 , A23V2200/324 , A23V2200/304 , A23V2200/3204
摘要： It is an object of the present invention to provide a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which has more potent antiallergic activity than the known lactic acid bacteria strains and produces γ-aminobutyric acid (GABA). It is another object of the present invention to provide beverages and foods containing cells of the aforementioned bacterial strain belonging to Lactobacillus brevis subspecies brevis, as well as antiallergic agents containing them as an active ingredient. The present invention provides a bacterial strain belonging to Lactobacillus brevis subspecies brevis, which: is capable of growing in effervescent alcoholic beverages, produces γ-aminobutyric acid (GABA), and has antiallergic activity.
摘要翻译： 本发明的目的是提供一种属于短乳短乳杆菌亚种短杆菌的细菌菌株，其具有比已知乳酸菌菌株更有效的抗过敏活性并产生γ-氨基丁酸（GABA）。 本发明的另一个目的是提供含有上述属于短乳内短杆菌亚种的上述细菌菌株的细胞的饮料和食品，以及含有它们作为活性成分的抗过敏剂。 本发明提供了一种属于短乳短乳短杆菌亚种的菌株，其能够在泡腾酒精饮料中生长，产生γ-氨基丁酸（GABA），并且具有抗过敏活性。
-
5.发明申请公开(公告)号：US20140220180A1
公开(公告)日：2014-08-07
申请号：US14245489
申请日：2014-04-04
发明人： Carol HENDRICK , Victor NSEREKO , William RUTHERFORD , Brenda SMILEY , Annette SPIELBAUER , Barbara RUSER
IPC分类号： A23K1/00
CPC分类号： A61K35/74 , A23K10/12 , A23K10/18 , A23K30/18 , C12N9/16 , C12P5/023 , C12R1/225 , C12R1/24 , C12R1/25 , Y02E50/343
摘要： Ferulate esterase producing bacterial strains or functional mutants thereof and methods of using ferulate esterase producing bacterial strains as forage additives are disclosed.
摘要翻译： 公开了产生酯酶的细菌菌株或其功能突变体，以及使用产生阿魏酸酯酶的细菌菌株作为饲料添加剂的方法。
-
公开(公告)号：US20090010903A1
公开(公告)日：2009-01-08
申请号：US12233013
申请日：2008-09-18
CPC分类号： A23K1/007 , A23K10/12 , A23K10/18 , A23K30/18 , A61K35/74 , C12N9/16 , C12P5/023 , C12R1/225 , C12R1/24 , C12R1/25 , Y02E50/343
摘要： Ferulate esterase producing bacterial strains or functional mutants thereof and methods of using ferulate esterase producing bacterial strains as forage additives are disclosed.
-
7.发明申请Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria 有权使用具有精氨酸去酰亚胺酶的细菌诱导凋亡和/或减少炎症反应和含有这种细菌的药物或饮食组合物公开(公告)号：US20030215429A1
公开(公告)日：2003-11-20
申请号：US10400675
申请日：2003-03-28
申请人： Mendes s.r.l.
发明人： Claudio De Simone
IPC分类号： A61K045/00 , C12N001/21
摘要： Disclosed is the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions containing such bacteria. Also disclosed is a strain of Lactobacillus brevis highly endowed with arginine deiminase.
摘要翻译： 公开了使用具有精氨酸脱亚氨酶的细菌诱导凋亡和/或减少炎症反应，以及含有这种细菌的药物或饮食组合物。 还公开了高度赋予精氨酸脱亚氨酶的短乳杆菌菌株。
-
公开(公告)号：US10004769B2
公开(公告)日：2018-06-26
申请号：US14895886
申请日：2014-06-02
申请人： CTC BIO, INC.
发明人： Hong Ryeol Jeon , Yoon-Mo Kang , Byeong-Gon Lee , Se-Young Kim , Go-Eun Shin
IPC分类号： C12N1/20 , A61K35/747 , C12R1/24 , C12P13/00
CPC分类号： A61K35/747 , A23Y2220/13 , C12N1/20 , C12P13/005 , C12R1/24
摘要： The present invention relates to a novel Lactobacillus brevis G-101 strain capable of decomposing monosodium L-glutamate (MSG), and a functional health food, a pharmaceutical composition, or a food product comprising the same as an active ingredient. More specifically, the strain is effective in reducing in vivo blood MSG levels of animals and attenuating MSG Symptom Complex, and thus can be used in a functional health food, a pharmaceutical composition, or a food product aiming to prevent in vivo absorption of MSG, which is known to be harmful, and improve the MSG Symptom Complex.
-
公开(公告)号：US20180021249A1
公开(公告)日：2018-01-25
申请号：US15450474
申请日：2017-03-06
申请人： BASF SE
发明人： Andreas REINDL , Rolf KNÖLL , Christine LANG , Markus VEEN , Eckhard BUDDE , Mewes BOETTNER
IPC分类号： A61K8/99 , A61Q15/00 , A61K35/747 , C12R1/225 , A61K35/74 , A61K35/744 , C12R1/24 , C12N1/20
CPC分类号： A61K8/99 , A61K35/74 , A61K35/744 , A61K35/747 , A61Q15/00 , C12N1/20 , C12R1/225 , C12R1/24
摘要： Described are microorganisms which are able to inhibit the formation of foot malodor by skin microorganisms. Also described are compositions comprising such microorganisms as well as the use of such microorganisms in cosmetic, prophylactic or therapeutic applications.
-
公开(公告)号：US20170333525A1
公开(公告)日：2017-11-23
申请号：US15669412
申请日：2017-08-04
发明人： Jürgen MAYER , Dirk HALLER , Anna ZHENCHUK , Thomas HOFMANN , Andreas DUNKEL , Michael SCHEMANN , Dagmar KRÜGER
CPC分类号： A61K38/1787 , A23L33/135 , A61K35/747 , A61K38/00 , A61K2035/115 , C12N1/00 , C12N1/26 , C12P13/001 , C12R1/225 , C12R1/24 , C12R1/25
摘要： The invention relates to acetylcholine-producing microorganisms for use in the prevention and/or treatment of intestinal diseases, and/or reduction of risks of intestinal diseases, and/or improvement of intestinal health as well as promoting healthy gut flora. The acetylcholine-producing microorganisms may be provided as a pharmaceutical dosage form or as additive to functional food or food supplemental products. Also encompassed is a method for the production of acetylcholine by use of Lactobacilli. Further the invention refers to microbially produced acetylcholine for use in the treatment and/or prevention of intestinal diseases.
-
-
-
-
-
-
-
-
-
搜索结果
51 条记录 (耗时 0.024 秒)
